EULAR Clinical Affairs Study Groups
Focus groups within the sphere of musculoskeletal medicine may apply for EULAR endorsement and also support through the Standing Committee for Clinical Affairs.
EULAR Systemic Lupus Erythematosus (SLE) Study Group
This is a study group that evolved from the EULAR Task Force on SLE that has published recommendations on the diagnosis and management of SLE, neuropsychiatric lupus and lupus nephritis, all published in the Ann Rheum Dis (available at the EULAR website). In addition, the task force has published recommendations on points to consider for conducting lupus clinical trials.
Annual report 2016
EULAR OA Trial Data Bank Study Group
Based on small to moderate effectiveness of the wide range of symptomatic treatments in OA, and the heterogeneity of OA patients, treatment guidelines for OA have stressed the need for research on clinical predictors of response to different treatments. EULAR endorses this inititative and will help increase the visibility towards all data-deliverers and all individuals interested in joining this study group.
Annual report 2016
EULAR Lupus Nephritis Trial Network Study Group
The mission of the Lupus Nephritis Trial Network (LNTN) is to improve outcomes for patients with lupus nephritis through: (1) the conduct of clinical trials designed to prevent chronic kidney disease and end-stage kidney failure, and (2) the development of clinical trial methodologies that improve and simplify the assessment of therapeutic agents.
Annual report 2015
EULAR Study Group on obesity, metabolic disorders and nutrition in RMDs
The aims of this study group are to build awareness on the problem of overweightness and obesity in all rheumatic diseases, to build up a consensus on how to deal in daily care with the problem and how to set up a prospective evaluation of the effectiveness of an intervention in weight control and incorrect nutrition in all rheumatic diseases.
Annual Report 2016
Study group application form